Velakast Tablet
Prescription Required
Marketed By
Aprazer Healthcare Pvt Ltd
Pack of
28 tablet
Salt Composition
Velpatasvir and Sofosbuvir
Storage
Keep in cold place
₹9399₹17349
45.82% Off
Inclusive of all taxes
1
Velakast Tablet
Delivering To: —
Overview
Velakast Tablet is a combination of Sofosbuvir and Velpatasvir, used to treat chronic (long-lasting) Hepatitis C Virus in adults. It slows the multiplication process of the virus and helps the immune system fight against the infection. Velakast is a fixed-dose tablet for oral administration. It is advised to take the dose every day at the same time. It may help your liver to recover.
Indication
Hepatitis C
Uses
Treatment of Chronic hepatitis C virus (HCV) infection
Side Effects
Velakast tablets may cause certain side effects. If side effects occur after administration or last longer than usual, contact your healthcare professional.
Nausea
Vomiting
Insomnia
Weight loss
Headache
Tiredness
Fatigue
Diarrhea
Urine infection
Dark colored urine
Dosage and Administration
Your healthcare provider will prescribe you the dose according to the severity of the disease. Take the dose exactly as prescribed, without any alteration/manipulation.
Please contact your healthcare provider immediately in case of an overdose.
Safety Advice
Alcohol
unsafe
It is advisable not to consume alcohol while taking this medicine.
Pregnancy
consult your doctor
Do not take Velakast tablets without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
caution
Do not take Velakast tablets without a doctor's consultation in case of kidney problems.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine.
Missed Doses
If you miss a dose of Velakast tablets, take it as soon as you remember. If it is already the time for the next dose, do not take 2 doses. Do not double the doses to catch up.
FAQs
Velakast is a combination of Sofosbuvir and Velpatasvir, used to treat chronic (long-lasting) Hepatitis C Virus in adults.
Take Velakast exactly as your healthcare provider tells you. Do not crush, chew, or break the tablet. Swallow it as a whole.
There can be side effects such as nausea, vomiting, insomnia, fatigue, urine infection, dark-colored urine, headache, and diarrhea. Please consult your healthcare provider if you experience these or any other side effects.
If you miss a dose, take it as soon as you remember. Do not take the missed dose if it is already the time for the next dose.
Your healthcare provider can make this clear if Velakast is safe for consumption during breastfeeding or not.
Trusted Medicines, Delivered Worldwide
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
Reference
Efficacy and safety of direct‑acting antiviral regimen for patients with hepatitis C virus genotype 2: A systematic review and meta‑analysis. (2024). BMC Gastroenterology, 24, Article 34? BioMed Central Sofosbuvir/velpatasvir in decompensated cirrhotic patients with genotype 1 and 2: A prospective multicenter real-world study in India. (2024). Journal of Clinical and Experimental Hepatology. PubMed+1jcehepatology.com+1
Sofosbuvir/velpatasvir/voxilaprevir for Hepatitis C virus retreatment in difficult‑to‑treat patients: A real‑life observational study from India. (2023). Journal of Clinical and Experimental Hepatology Sofosbuvir–velpatasvir single‑tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India. (2023). BMC Medicine / multicenter Indian cohort. PMC
Related Products
MARKETER DETAILS
Aprazer Healthcare Pvt Ltd
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.